Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Supportive Care in Cancer
Erschienen in: Supportive Care in Cancer 8/2016

06.04.2016 | Commentary

Left behind: cancer disparities in the developed world

verfasst von: Niharika Dixit, Gregory B. Crawford, Manon Lemonde, Cynthia N. Rittenberg, Paz Fernández-Ortega

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Huge advances have been made in cancer treatments over recent decades; however, significant disparities still exist in the developed world on the basis of race, socioeconomic status, education level, geographical location, and immigration status and in the United States, insurance status. Cancer disparities persist in the continuum of cancer care from risk factors, screening, diagnosis, treatment, survivorship, and end-of-life care. The causes of disparities are complex and multifactorial. The MASCC (Multinational Association of Supportive Care in Cancer) Education Study Group would like to propose a framework of cancer disparities from a social perspective utilizing “social determinants of health” as delineated by the World Health Organization and highlight an unmet need for research and policy innovations to address cancer disparities in developed world.
Literatur
1.
Duffy S, Richards M, Selby P, Lawler M (2013) Addressing cancer disparities in Europe: a multifaceted problem that requires interdisciplinary solutions. Oncologist 18(12):e29–e30CrossRefPubMedPubMedCentral
2.
Albano JD, Ward E, Jemal A, et al. (2007) Cancer mortality in the United States by education level and race. J Natl Cancer Inst 99(18):1384–1394CrossRefPubMed
3.
Aizer AA, Wilhite TJ, Chen MH, et al. (2014) Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer 120(10):1532–1539CrossRefPubMed
4.
Byers TE, Wolf HJ, Bauer KR, et al. (2008) The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care study. Cancer 113(3):582–591
5.
Chong A, Roder D (2010) Exploring differences in survival from cancer among Indigenous and non-Indigenous australians: Implications for health service delivery and research. Asian Pac J Cancer Prev 11(4):953–961PubMed
6.
Zeng C, Wen W, Morgans AK, Pao W, Shu XO, Zheng W (2015) Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program in the United States, 1990 to 2010. JAMA Oncol 1(1):88–96
7.
8.
Fiscella K, Franks P, Meldrum S (2004) Estimating racial/ethnic disparity in mammography rates: It all depends on how you ask the question. Prev Med 39(2):399–403
9.
Mullins CD, Blatt L, Gbarayor CM, Yang HW, Baquet C (2005) Health disparities: A barrier to high-quality care. Am J Health Syst Pharm 62(18):1873–1882CrossRefPubMedPubMedCentral
10.
Abdollah F, Sammon JD, Majumder K, et al. (2015) Racial disparities in end-of-life care among patients with prostate cancer: a population-based study. J Natl Compr Cancer Netw 13(9):1131–1138
11.
Australian Institute of Health and Welfare (2011) Cancer in Australia: Actual incidence and mortality data from 1982 to 2007 and projections to 2010. Asia Pac J Clin Oncol 7(4):325–338CrossRef
12.
Cunningham J, Rumbold AR, Zhang X, Condon JR (2008) Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia. Lancet Oncol 9(6):585–595CrossRefPubMed
13.
Patel MI, Schupp CW, Gomez SL, Chang ET, Wakelee HA (2013) How do social factors explain outcomes in non-small-cell lung cancer among Hispanics in california? explaining the Hispanic paradox. J Clin Oncol 31(28):3572–3578CrossRefPubMedPubMedCentral
14.
Survival of cancer patients in Europe: The EUROCARE-2 study. IARC Sci Publ. 1999;(151)(151):1–572.
15.
Abdel-Rahman M, Stockton D, Rachet B, Hakulinen T, Coleman MP (2009) What if cancer survival in Britain were the same as in Europe: How many deaths are avoidable? Br J Cancer 101(Suppl 2):S115–S124CrossRefPubMedPubMedCentral
16.
Dumont DM, Allen SA, Brockmann BW, Alexander NE, Rich JD (2013) Incarceration, community health, and racial disparities. J Health Care Poor Underserved 24(1):78–88CrossRefPubMed
17.
Flores YN, Davidson PL, Nakazono TT, Carreon DC, Mojica CM, Bastani R. Neighborhood socio-economic disadvantage and race/ethnicity as predictors of breast cancer stage at diagnosis. BMC Public Health. 2013;13:1061–2458-13-1061.
18.
Busch EL, Martin C, DeWalt DA, Sandler RS (2015) Functional health literacy, chemotherapy decisions, and outcomes among a colorectal cancer cohort. Cancer Control 22(1):95–101PubMedPubMedCentral
19.
Shariff-Marco S, Yang J, John EM, et al. (2014) Impact of neighborhood and individual socioeconomic status on survival after breast cancer varies by race/ethnicity: The neighborhood and breast cancer study. Cancer Epidemiol Biomark Prev 23(5):793–811CrossRef
20.
Polite BN (2015) States as the laboratory for democracy: Is anybody paying attention, and does anybody care? J Clin Oncol 33(8):815–816CrossRefPubMed
21.
Braun KL, Tsark J, Santos LA, Abrigo L (2003) Native Hawaiian Cancer Awareness Research and Training Network. ‘Imi hale—the Native Hawaiian cancer awareness, research, and training network: second-year status report. Asian Am Pac Isl J Health 10(1):4–16PubMedPubMedCentral
22.
Victor RG, Ravenell JE, Freeman A, et al. (2011) Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med 171(4):342–350CrossRefPubMed
Metadaten
Titel
Left behind: cancer disparities in the developed world
verfasst von
Niharika Dixit
Gregory B. Crawford
Manon Lemonde
Cynthia N. Rittenberg
Paz Fernández-Ortega
Publikationsdatum
06.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2016
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3192-4

Weitere Artikel der Ausgabe 8/2016

Supportive Care in Cancer 8/2016 Zur Ausgabe

Original Article

Demographic, clinical, psychosocial, and environmental correlates of objectively assessed physical activity among breast cancer survivors

Letter to the editor

Re: “Prediction of skeletal-related events in patients with non-small cell lung cancer”—use of Spine Instability Neoplastic Score (SINS)

Original Article

Cancer and fertility preservation in Puerto Rico: a qualitative study of healthcare provider perceptions

Review Article

The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review

Original Article

Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy

Original Article

Methadone as first-line opioid treatment for cancer pain in a developing country palliative care unit

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

ASS schützt nicht vor Brustkrebsrezidiven

02.05.2024 Mammakarzinom Nachrichten

Nützt nichts und ist vielleicht sogar schädlich: In einer Phase-3-Studie konnten täglich 300 mg ASS keine Brustkrebsrezidive bei Frauen vermeiden, die ein hohes Risiko für eine Tumorrückkehr aufwiesen. Tendenziell traten unter ASS sogar häufiger Rezidive auf als unter Placebo.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise